Related references
Note: Only part of the references are listed.Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity
Soma Roy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors
A. Prasanth Saraswati et al.
DRUG DISCOVERY TODAY (2019)
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives
Marta Recagni et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
In perspective: An update on telomere targeting in cancer
Eric T. Sugarman et al.
MOLECULAR CARCINOGENESIS (2019)
Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes
Zahra Ameri et al.
LIFE SCIENCES (2019)
Design, synthesis of 4,5-diazafluorene derivatives and their anticancer activity via targeting telomeric DNA G-quadruplex
Kang Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, Synthesis and Molecular Docking Analysis of Flavonoid Derivatives as Potential Telomerase Inhibitors
Zhan-Fang Fan et al.
MOLECULES (2019)
A Review Exploring Therapeutic Worth of 1,3,4-Oxadiazole Tailored Compounds
Garima Verma et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Synthesis and Biological of Novel Myricetin Derivatives Containing 1,3,4-Oxadiazoles
Cheng Zhang et al.
CHINESE JOURNAL OF ORGANIC CHEMISTRY (2019)
Exploring 1,3,4-Oxadiazole Scaffold for Anti-inflammatory and Analgesic Activities: A Review of Literature From 2005-2016
Gita Chawla et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin
Jie Quan Wang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole
Teresa Glomb et al.
MOLECULES (2018)
Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands
Yin Jiang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
New prospects for targeting telomerase beyond the telomere
Greg M. Arndt et al.
NATURE REVIEWS CANCER (2016)
Synthesis of a platinum(II) complex with 2-(4-methoxy-phenyl)imidazo [4,5-f]-[1,10] phenanthrolin and study of its antitumor activity
Qi-Pin Qin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Novel myricetin derivatives: Design, synthesis and anticancer activity
Wei Xue et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, synthesis, and antiviral activity of novel rutin derivatives containing 1, 4-pentadien-3-one moiety
Yu Han et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Tumor Cell Apoptosis by Organoplatinum(II) Complexes with Oxoisoaporphine
Zhen-Feng Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness
Francesco Vasuri et al.
HISTOPATHOLOGY (2015)
Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents
Fei Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Inhibition of Human Dyskerin as a New Approach to Target Ribosome Biogenesis
Laura Rocchi et al.
PLOS ONE (2014)
Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent
Juan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis
Bei Liu et al.
PLOS ONE (2012)
Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents
Xiao-Min Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Inhibition of Cell Proliferation by Quindoline Derivative (SYUIQ-05) through its Preferential Interaction with c-myc Promoter G-Quadruplex
Tian-Miao Ou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents
Z. Li et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Symmetrical Bisbenzimidazoles with Benzenediyl Spacer: The Role of the Shape of the Ligand on the Stabilization and Structural Alterations in Telomeric G-Quadruplex DNA and Telomerase Inhibition
Santanu Bhattacharya et al.
BIOCONJUGATE CHEMISTRY (2010)
Identification of small molecule inhibitors of telomerase activity through transcriptional regulation of hTERT and calcium induction pathway in human lung adenocarcinoma A549 cells
Yerra Koteswara Rao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1,3,4-oxadiazole moiety as potential antitumor agents
Qing-Zhong Zheng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Single-Molecule Analysis of the Human Telomerase RNA • Dyskerin Interaction and the Effect of Dyskeratosis Congenita Mutations
Beth Ashbridge et al.
BIOCHEMISTRY (2009)
DKC1 overexpression associated with prostate cancer progression
P. Sieron et al.
BRITISH JOURNAL OF CANCER (2009)
Real-time PCR quantification of human DKC1 expression in colorectal cancer
Mimmo Turano et al.
ACTA ONCOLOGICA (2008)
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita
Tom Vulliamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10
Amanda J. Walne et al.
HUMAN MOLECULAR GENETICS (2007)
Elucidation of fatty acid amide hydrolase inhibition by potent α-ketoheterocycle derivatives from Monte Carlo simulations
CRW Guimaraes et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
H El-Daly et al.
BLOOD (2005)
Catecholic flavonoids acting as telomerase inhibitors
M Menichincheri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Telomerase in the human organism
K Collins et al.
ONCOGENE (2002)
Share Paper
